India’s largest Biotechnology company, Biocon, reported September quarter profit raised 52 per cent to Rs 146.7 crore against Rs 97 crore in the same period last year, on improved business growth across small molecules, biologics and research services. The second quarter profit in FY16 is before exceptional items.
Long Term Investment Calls by Expert
Biocon Ltd : Buy Biocon at around 880 to 885 with targets 915, 935 With Stop Loss 841. You can hold 1 month.